Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1984 1
1988 2
1989 1
1990 3
1991 2
1994 3
1995 4
1996 4
1998 2
1999 1
2003 3
2004 3
2005 6
2006 7
2007 6
2008 6
2009 8
2010 6
2011 16
2012 11
2013 8
2014 8
2015 11
2016 13
2017 13
2018 12
2019 10
2020 13
2021 6
2022 8
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.
Fong L, Hotson A, Powderly JD, Sznol M, Heist RS, Choueiri TK, George S, Hughes BGM, Hellmann MD, Shepard DR, Rini BI, Kummar S, Weise AM, Riese MJ, Markman B, Emens LA, Mahadevan D, Luke JJ, Laport G, Brody JD, Hernandez-Aya L, Bonomi P, Goldman JW, Berim L, Renouf DJ, Goodwin RA, Munneke B, Ho PY, Hsieh J, McCaffery I, Kwei L, Willingham SB, Miller RA. Fong L, et al. Among authors: mahadevan d. Cancer Discov. 2020 Jan;10(1):40-53. doi: 10.1158/2159-8290.CD-19-0980. Epub 2019 Nov 15. Cancer Discov. 2020. PMID: 31732494 Free PMC article. Clinical Trial.
Pharmacotherapeutic options for pancreatic ductal adenocarcinoma.
Sardar M, Recio-Boiles A, Mody K, Karime C, Chandana SR, Mahadevan D, Starr J, Jones J, Borad M, Babiker H. Sardar M, et al. Among authors: mahadevan d. Expert Opin Pharmacother. 2022 Dec;23(18):2079-2089. doi: 10.1080/14656566.2022.2149322. Epub 2022 Nov 28. Expert Opin Pharmacother. 2022. PMID: 36394449 Review.
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
Chandana S, Babiker HM, Mahadevan D. Chandana S, et al. Among authors: mahadevan d. Expert Opin Investig Drugs. 2019 Feb;28(2):161-177. doi: 10.1080/13543784.2019.1557145. Epub 2018 Dec 16. Expert Opin Investig Drugs. 2019. PMID: 30539678 Review.
A call to arms: Unifying the fight against resistance.
Kaushansky A, Hedstrom L, Goldman A, Singh J, Yang PL, Rathod PK, Cynamon M, Wodarz D, Mahadevan D, Tomaras A, Navia MA, Schiffer CA. Kaushansky A, et al. Among authors: mahadevan d. Sci Signal. 2018 Oct 23;11(553):eaav0442. doi: 10.1126/scisignal.aav0442. Sci Signal. 2018. PMID: 30352947 Free PMC article.
Quo vadis, foot & ankle research? A review.
Krause F, Herrera M, Walcher M, Mahadevan D, Michels F. Krause F, et al. Among authors: mahadevan d. Foot Ankle Surg. 2023 Oct;29(7):502-505. doi: 10.1016/j.fas.2023.08.003. Epub 2023 Aug 19. Foot Ankle Surg. 2023. PMID: 37648639 Review.
A comprehensive review of protein kinase inhibitors for cancer therapy.
Kannaiyan R, Mahadevan D. Kannaiyan R, et al. Among authors: mahadevan d. Expert Rev Anticancer Ther. 2018 Dec;18(12):1249-1270. doi: 10.1080/14737140.2018.1527688. Epub 2018 Oct 9. Expert Rev Anticancer Ther. 2018. PMID: 30259761 Free PMC article. Review.
Novel therapeutics for aggressive non-Hodgkin's lymphoma.
Mahadevan D, Fisher RI. Mahadevan D, et al. J Clin Oncol. 2011 May 10;29(14):1876-84. doi: 10.1200/JCO.2010.32.7171. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21483007 Free PMC article. Review.
178 results